These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32309282)

  • 1. An Appraisal on the Value of Using Nutraceutical Based Senolytics and Senostatics in Aging.
    Kaur A; Macip S; Stover CM
    Front Cell Dev Biol; 2020; 8():218. PubMed ID: 32309282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavonoids in Skin Senescence Prevention and Treatment.
    Domaszewska-Szostek A; Puzianowska-Kuźnicka M; Kuryłowicz A
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases.
    Kang C
    Mol Cells; 2019 Dec; 42(12):821-827. PubMed ID: 31838837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMPK-mediated senolytic and senostatic activity of quercetin surface functionalized Fe
    Lewinska A; Adamczyk-Grochala J; Bloniarz D; Olszowka J; Kulpa-Greszta M; Litwinienko G; Tomaszewska A; Wnuk M; Pazik R
    Redox Biol; 2020 Jan; 28():101337. PubMed ID: 31622846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senolytics and senostatics as adjuvant tumour therapy.
    Short S; Fielder E; Miwa S; von Zglinicki T
    EBioMedicine; 2019 Mar; 41():683-692. PubMed ID: 30737084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senotherapy preserves resilience in aging.
    Mikawa T; Yoshida K; Kondoh H
    Geriatr Gerontol Int; 2024 Aug; ():. PubMed ID: 39098000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.
    Robbins PD; Jurk D; Khosla S; Kirkland JL; LeBrasseur NK; Miller JD; Passos JF; Pignolo RJ; Tchkonia T; Niedernhofer LJ
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():779-803. PubMed ID: 32997601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senolytics and the compression of late-life mortality.
    Kowald A; Kirkwood TBL
    Exp Gerontol; 2021 Nov; 155():111588. PubMed ID: 34637949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies.
    Wyld L; Bellantuono I; Tchkonia T; Morgan J; Turner O; Foss F; George J; Danson S; Kirkland JL
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32752135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A focused natural compound screen reveals senolytic and senostatic effects of
    Kim EJ; Woo J; Shin S; Choi H; Kim Y; Kim J; Kang C
    Anim Cells Syst (Seoul); 2022; 26(6):310-317. PubMed ID: 36605596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-aging: senolytics or gerostatics (unconventional view).
    Blagosklonny MV
    Oncotarget; 2021 Aug; 12(18):1821-1835. PubMed ID: 34504654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-senescence compounds: A potential nutraceutical approach to healthy aging.
    Gurău F; Baldoni S; Prattichizzo F; Espinosa E; Amenta F; Procopio AD; Albertini MC; Bonafè M; Olivieri F
    Ageing Res Rev; 2018 Sep; 46():14-31. PubMed ID: 29742452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools.
    Knoppert SN; Valentijn FA; Nguyen TQ; Goldschmeding R; Falke LL
    Front Pharmacol; 2019; 10():770. PubMed ID: 31354486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting cellular senescence as a new approach to chronic obstructive pulmonary disease therapy.
    Barnes PJ
    Curr Opin Pharmacol; 2021 Feb; 56():68-73. PubMed ID: 33326912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the discovery of senolytics.
    Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
    Mech Ageing Dev; 2021 Dec; 200():111587. PubMed ID: 34656616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting aging mechanisms: pharmacological perspectives.
    Moskalev A; Guvatova Z; Lopes IA; Beckett CW; Kennedy BK; De Magalhaes JP; Makarov AA
    Trends Endocrinol Metab; 2022 Apr; 33(4):266-280. PubMed ID: 35183431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senolytics and cell senescence: historical and evolutionary perspectives.
    Finch CE
    Evol Med Public Health; 2024; 12(1):82-85. PubMed ID: 38757096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic Effects of Tocotrienols and Quercetin on Cellular Senescence: Introducing the Perspective of Senolytic Effects of Phytochemicals.
    Malavolta M; Pierpaoli E; Giacconi R; Costarelli L; Piacenza F; Basso A; Cardelli M; Provinciali M
    Curr Drug Targets; 2016; 17(4):447-59. PubMed ID: 26343116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New agents that target senescent cells: the flavone, fisetin, and the BCL-X
    Zhu Y; Doornebal EJ; Pirtskhalava T; Giorgadze N; Wentworth M; Fuhrmann-Stroissnigg H; Niedernhofer LJ; Robbins PD; Tchkonia T; Kirkland JL
    Aging (Albany NY); 2017 Mar; 9(3):955-963. PubMed ID: 28273655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Potential of Senolytic Drugs.
    Kirkland JL; Tchkonia T; Zhu Y; Niedernhofer LJ; Robbins PD
    J Am Geriatr Soc; 2017 Oct; 65(10):2297-2301. PubMed ID: 28869295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.